These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 20826546)
21. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription. Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991 [TBL] [Abstract][Full Text] [Related]
22. Cross-talk between signal transducer and activator of transcription (Stat5) and thyroid hormone receptor-beta 1 (TRbeta1) signaling pathways. Favre-Young H; Dif F; Roussille F; Demeneix BA; Kelly PA; Edery M; de Luze A Mol Endocrinol; 2000 Sep; 14(9):1411-24. PubMed ID: 10976919 [TBL] [Abstract][Full Text] [Related]
23. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription. Ferrag F; Chiarenza A; Goffin V; Kelly PA Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989 [TBL] [Abstract][Full Text] [Related]
24. New mechanisms for PRLr action in breast cancer. Clevenger CV; Gadd SL; Zheng J Trends Endocrinol Metab; 2009 Jul; 20(5):223-9. PubMed ID: 19535262 [TBL] [Abstract][Full Text] [Related]
25. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625 [TBL] [Abstract][Full Text] [Related]
26. Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. Swaminathan G; Varghese B; Thangavel C; Carbone CJ; Plotnikov A; Kumar KG; Jablonski EM; Clevenger CV; Goffin V; Deng L; Frank SJ; Fuchs SY J Endocrinol; 2008 Feb; 196(2):R1-7. PubMed ID: 18252943 [TBL] [Abstract][Full Text] [Related]
27. Impaired turnover of prolactin receptor contributes to transformation of human breast cells. Plotnikov A; Varghese B; Tran TH; Liu C; Rui H; Fuchs SY Cancer Res; 2009 Apr; 69(7):3165-72. PubMed ID: 19276348 [TBL] [Abstract][Full Text] [Related]
28. Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase. Li Y; Kumar KG; Tang W; Spiegelman VS; Fuchs SY Mol Cell Biol; 2004 May; 24(9):4038-48. PubMed ID: 15082796 [TBL] [Abstract][Full Text] [Related]
29. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling. García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015 [TBL] [Abstract][Full Text] [Related]
30. Signal regulatory protein alpha ligation induces macrophage nitric oxide production through JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/NAPDH oxidase/H2O2-dependent pathways. Alblas J; Honing H; de Lavalette CR; Brown MH; Dijkstra CD; van den Berg TK Mol Cell Biol; 2005 Aug; 25(16):7181-92. PubMed ID: 16055727 [TBL] [Abstract][Full Text] [Related]
31. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin. Jabbour HN; Critchley HO; Boddy SC J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641 [TBL] [Abstract][Full Text] [Related]
32. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells. Russell DL; Richards JS Mol Endocrinol; 1999 Dec; 13(12):2049-64. PubMed ID: 10598581 [TBL] [Abstract][Full Text] [Related]
33. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor. Tomic S; Chughtai N; Ali S Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404 [TBL] [Abstract][Full Text] [Related]
34. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation. Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911 [TBL] [Abstract][Full Text] [Related]
35. Functional characterization of the intermediate isoform of the human prolactin receptor. Kline JB; Roehrs H; Clevenger CV J Biol Chem; 1999 Dec; 274(50):35461-8. PubMed ID: 10585417 [TBL] [Abstract][Full Text] [Related]
36. Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells. Scotti ML; Langenheim JF; Tomblyn S; Springs AE; Chen WY Breast Cancer Res Treat; 2008 Sep; 111(2):241-50. PubMed ID: 17955362 [TBL] [Abstract][Full Text] [Related]
37. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136 [TBL] [Abstract][Full Text] [Related]
38. PRL/PRLR Can Promote Insulin Resistance by Activating the JAK2/STAT5 Signaling Pathway. Wang PY; Jin CC; Liu C; Zhao ZJ; Yang HY Comput Math Methods Med; 2022; 2022():1456187. PubMed ID: 36238467 [TBL] [Abstract][Full Text] [Related]